Teleflex Incorporated (TFX) analyst actions
Rating and price-target actions on TFX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the TFX overview →
4 measured TFX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Teleflex Initiates Enrollment in Global BIOMAG™-III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold | Press release | +0.80% | +2.52% | |
| Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution | Press release | -0.19% | +0.59% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Shareholders to Reach Out | Press release | -0.08% | +0.66% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Stockholders to Reach Out | Press release | -0.47% | -3.53% |
Keep exploring
More TFX: earnings → · SEC filings → · TFX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CANTEL MEDICAL CORP (CMD) | 468 | 0.00% | 49% |
| BioLife Solutions, Inc. (BLFS) | 465 | +0.22% | 52% |
| CAS MEDICAL SYSTEMS (CASM) | 459 | 0.00% | 35% |
| Emergent BioSolutions Inc. (EBS) | 458 | -0.08% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.